Why is it that Idec Pharmaceuticals is rarely given credit for discovering Rituxan (MabThera), and never given credit for developing it? I personally am very tired of IDEC's collaborators taking credit in press releases and news reports. The collaborators get repayed handsomly for their financial contributions. Why do they not give credit where credit is due? Over more than a decade IDEC discovered and dilegently developed C2B8. What will it take for IDEC to get the recognition it deserves? Doesn't Genentech,Roche,and Zenyaku get enough press off the backs of developing biotech companys?